Move to topTop
July 04, 2018

TOKYO, JAPAN - July 4, 2018 - Terumo Corporation (TSE: 4543) today announced shipping delays for products from its Ashitaka Factory in Shizuoka, Japan. This factory produces certain cardiovascular products. No other Terumo factories are affected by this issue.

While Terumo was pursuing enhancements of its manufacturing capabilities at the Ashitaka Factory, the company discovered that there were challenges in the procedure that optimizes the sterilization process. Shipments of certain products from this factory have been placed on hold in late May, based on its internal rules.

Terumo is gradually resuming shipments as it confirms the procedure. The company is aiming to resume full shipping by mid-August.

Terumo is now assessing the financial impact and will disclose findings as they are confirmed. The company plans to provide updates on the progress of this matter at the 1st quarter financial results announcement on August 8th.

Based on the company's corporate mission, "Contributing to Society through Healthcare," Terumo is making every effort to minimize disruption of product supply.

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.


Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.